Thyroid cancer is among the most common cancers in the United States. Thyroid nodules are frequently detected through ultrasound (US) imaging, and some require further evaluation via fine-needle aspiration (FNA) biopsy. Despite its effectiveness, FNA often leads to unnecessary biopsies of benign nodules, causing patient discomfort and anxiety. To address this, the American College of Radiology Thyroid Imaging Reporting and Data System (TI-RADS) has been developed to reduce benign biopsies. However, such systems are limited by interobserver variability. Recent deep learning approaches have sought to improve risk stratification, but they often fail to utilize the rich temporal and spatial context provided by US cine clips, which contain dynamic global information and surrounding structural changes across various views. In this work, we propose the Spatio-Temporal Cross Attention for Cine Thyroid Ultrasound Time Series Classification (STACT-Time) model, a novel representation learning framework that integrates imaging features from US cine clips with features from segmentation masks automatically generated by a pretrained model. By leveraging self-attention and cross-attention mechanisms, our model captures the rich temporal and spatial context of US cine clips while enhancing feature representation through segmentation-guided learning. Our model improves malignancy prediction compared to state-of-the-art models, achieving a cross-validation precision of 0.91 (plus or minus 0.02) and an F1 score of 0.89 (plus or minus 0.02). By reducing unnecessary biopsies of benign nodules while maintaining high sensitivity for malignancy detection, our model has the potential to enhance clinical decision-making and improve patient outcomes.

Federated learning has significantly advanced distributed training of machine learning models across decentralized data sources. However, existing frameworks often lack comprehensive solutions that combine uncertainty quantification, interpretability, and robustness. To address this, we propose FedNAM+, a federated learning framework that integrates Neural Additive Models (NAMs) with a novel conformal prediction method to enable interpretable and reliable uncertainty estimation. Our method introduces a dynamic level adjustment technique that utilizes gradient-based sensitivity maps to identify key input features influencing predictions. This facilitates both interpretability and pixel-wise uncertainty estimates. Unlike traditional interpretability methods such as LIME and SHAP, which do not provide confidence intervals, FedNAM+ offers visual insights into prediction reliability. We validate our approach through experiments on CT scan, MNIST, and CIFAR datasets, demonstrating high prediction accuracy with minimal loss (e.g., only 0.1% on MNIST), along with transparent uncertainty measures. Visual analysis highlights variable uncertainty intervals, revealing low-confidence regions where model performance can be improved with additional data. Compared to Monte Carlo Dropout, FedNAM+ delivers efficient and global uncertainty estimates with reduced computational overhead, making it particularly suitable for federated learning scenarios. Overall, FedNAM+ provides a robust, interpretable, and computationally efficient framework that enhances trust and transparency in decentralized predictive modeling.

Purpose: To develop an age prediction model which is interpretable and robust to demographic and technological variances in brain MRI scans. Materials and Methods: We propose a transformer-based architecture that leverages self-supervised pre-training on large-scale datasets. Our model processes pseudo-3D T1-weighted MRI scans from three anatomical views and incorporates brain volumetric information. By introducing a stem architecture, we reduce the conventional quadratic complexity of transformer models to linear complexity, enabling scalability for high-dimensional MRI data. We trained our model on ADNI2 $\&$ 3 (N=1348) and OASIS3 (N=716) datasets (age range: 42 - 95) from the North America, with an 8:1:1 split for train, validation and test. Then, we validated it on the AIBL dataset (N=768, age range: 60 - 92) from Australia. Results: We achieved an MAE of 3.65 years on ADNI2 $\&$ 3 and OASIS3 test set and a high generalizability of MAE of 3.54 years on AIBL. There was a notable increase in brain age gap (BAG) across cognitive groups, with mean of 0.15 years (95% CI: [-0.22, 0.51]) in CN, 2.55 years ([2.40, 2.70]) in MCI, 6.12 years ([5.82, 6.43]) in AD. Additionally, significant negative correlation between BAG and cognitive scores was observed, with correlation coefficient of -0.185 (p < 0.001) for MoCA and -0.231 (p < 0.001) for MMSE. Gradient-based feature attribution highlighted ventricles and white matter structures as key regions influenced by brain aging. Conclusion: Our model effectively fused information from different views and volumetric information to achieve state-of-the-art brain age prediction accuracy, improved generalizability and interpretability with association to neurodegenerative disorders.

Diseases underlying osteolytic lesions in jaws are characterized by the absorption of bone tissue and are often asymptomatic, delaying their diagnosis. Well-defined lesions (benign cyst-like lesions) and ill-defined lesions (osteomyelitis or malignancy) can be detected early in a panoramic radiograph (PR) by an experienced examiner, but most dentists lack appropriate training. To support dentists, this study aimed to develop and evaluate deep learning models for the detection of osteolytic lesions in PRs. A dataset of 676 PRs (165 well-defined, 181 ill-defined, 330 control) was collected from the Department of Oral and Maxillofacial Surgery at Charité Berlin, Germany. The osteolytic lesions were pixel-wise segmented and labeled as well-defined or ill-defined. Four model architectures for instance segmentation (Mask R-CNN with a Swin-Tiny or ResNet-50 backbone, Mask DINO, and YOLOv5) were employed with five-fold cross-validation. Their effectiveness was evaluated with sensitivity, specificity, F1-score, and AUC and failure cases were shown. Mask R-CNN with a Swin-Tiny backbone was most effective (well-defined F1 = 0.784, AUC = 0.881; ill-defined F1 = 0.904, AUC = 0.971) and the model architectures including vision transformer components were more effective than those without. Model mistakes were observed around the maxillary sinus, at tooth extraction sites, and for radiolucent bands. Promising deep learning models were developed for the detection of osteolytic lesions in PRs, particularly those with vision transformer components (Mask R-CNN with Swin-Tiny and Mask DINO). These results underline the potential of vision transformers for enhancing the automated detection of osteolytic lesions, offering a significant improvement over traditional deep learning models.

Advances in biomarkers and pathophysiology of vascular contributions to cognitive impairment and dementia (VCID) are expected to bring greater mechanistic insights, more targeted treatments, and potentially disease-modifying therapies. The 2025 Annual Workshop of the Albert Research Institute for White Matter and Cognition, sponsored by the Leo and Anne Albert Charitable Trust since 2015, focused on novel biomarkers for VCID. The meeting highlighted the complexity of dementia, emphasizing that the majority of cases involve multiple brain pathologies, with vascular pathology typically present. Potential novel approaches to diagnosis of disease processes and progression that may result in VCID included measures of microglial senescence and retinal changes, as well as artificial intelligence (AI) integration of multimodal datasets. Proteomic studies identified plasma proteins associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL; a rare genetic disorder affecting brain vessels) and age-related vascular pathology that suggested potential therapeutic targets. Blood-based microglial and brain-derived extracellular vesicles are promising tools for early detection of brain inflammation and other changes that have been associated with cognitive decline. Imaging measures of blood perfusion, oxygen extraction, and cerebrospinal fluid (CSF) flow were discussed as potential VCID biomarkers, in part because of correlations with classic pathological Alzheimer's disease (AD) biomarkers. MRI-visible perivascular spaces, which may be a novel imaging biomarker of sleep-driven glymphatic waste clearance dysfunction, are associated with vascular risk factors, lower cognitive function, and various brain pathologies including Alzheimer's, Parkinson's and cerebral amyloid angiopathy (CAA). People with Down syndrome are at high risk for dementia. Individuals with Down syndrome who develop dementia almost universally experience mixed brain pathologies, with AD pathology and cerebrovascular pathology being the most common. This follows the pattern in the general population where mixed pathologies are also predominant in the brains of people clinically diagnosed with dementia, including AD dementia. Intimate partner violence-related brain injury, hypertension's impact on dementia risk, and the promise of remote ischemic conditioning for treating VCID were additional themes.

To develop a radiomics risk-predictive model for differentiating the different stages of Hashimoto's thyroiditis (HT). Data from patients with HT who underwent definitive surgical pathology between January 2018 and December 2023 were retrospectively collected and categorized into early HT (HT patients with simple positive antibodies or simultaneously accompanied by elevated thyroid hormones) and late HT (HT patients with positive antibodies and beginning to present subclinical hypothyroidism or developing hypothyroidism). Ultrasound images and five clinical and 12 laboratory indicators were obtained. Six classifiers were used to construct radiomics models. The gradient boosting decision tree (GBDT) classifier was used to screen for the best features to explore the main risk factors for differentiating early HT. The performance of each model was evaluated by receiver operating characteristic (ROC) curve. The model was validated using one internal and two external test cohorts. A total of 785 patients were enrolled. Extreme gradient boosting (XGBOOST) showed best performance in the training cohort, with an AUC of 0.999 (0.998, 1), and AUC values of 0.993 (0.98, 1), 0.947 (0.866, 1), and 0.98 (0.939, 1), respectively, in the internal test, first external, and second external cohorts. Ultrasound radiomic features contributed to 78.6% (11/14) of the model. The first-order feature of traverse section of thyroid ultrasound image, texture feature gray-level run length matrix (GLRLM) of longitudinal section of thyroid ultrasound image and free thyroxine showed the greatest contributions in the model. Our study developed and tested a risk-predictive model that effectively differentiated HT stages to more precisely and actively manage patients with HT at an earlier stage.

A retrospective analysis. The aim of this study was to identify a robust radiomic signature from deep learning segmentations for intervertebral disc (IVD) degeneration classification. Low back pain (LBP) is the most common musculoskeletal symptom worldwide and IVD degeneration is an important contributing factor. To improve the quantitative phenotyping of IVD degeneration from T2-weighted magnetic resonance imaging (MRI) and better understand its relationship with LBP, multiple shape and intensity features have been investigated. IVD radiomics have been less studied but could reveal sub-visual imaging characteristics of IVD degeneration. We used data from Northern Finland Birth Cohort 1966 members who underwent lumbar spine T2-weighted MRI scans at age 45-47 (n=1397). We used a deep learning model to segment the lumbar spine IVDs and extracted 737 radiomic features, as well as calculating IVD height index and peak signal intensity difference. Intraclass correlation coefficients across image and mask perturbations were calculated to identify robust features. Sparse partial least squares discriminant analysis was used to train a Pfirrmann grade classification model. The radiomics model had balanced accuracy of 76.7% (73.1-80.3%) and Cohen's Kappa of 0.70 (0.67-0.74), compared to 66.0% (62.0-69.9%) and 0.55 (0.51-0.59) for an IVD height index and peak signal intensity model. 2D sphericity and interquartile range emerged as radiomics-based features that were robust and highly correlated to Pfirrmann grade (Spearman's correlation coefficients of -0.72 and -0.77 respectively). Based on our findings these radiomic signatures could serve as alternatives to the conventional indices, representing a significant advance in the automated quantitative phenotyping of IVD degeneration from standard-of-care MRI.

Background & purposeLate radiation-associated dysphagia after head and neck cancer (HNC) significantly impacts patients health and quality of life. Conventional normal tissue complication probability (NTCP) models use discrete dose parameters to predict toxicity risk but fail to fully capture the complexity of this side effect. Deep learning (DL) offers potential improvements by incorporating 3D dose data for all anatomical structures involved in swallowing. This study aims to enhance dysphagia prediction with 3D DL NTCP models compared to conventional NTCP models. Materials & methodsA multi-institutional cohort of 1484 HNC patients was used to train and validate a 3D DL model (Residual Network) incorporating 3D dose distributions, organ-at-risk segmentations, and CT scans, with or without patient- or treatment-related data. Predictions of grade [&ge;]2 dysphagia (CTCAEv4) at six months post-treatment were evaluated using area under the curve (AUC) and calibration curves. Results were compared to a conventional NTCP model based on pre-treatment dysphagia, tumour location, and mean dose to swallowing organs. Attention maps highlighting regions of interest for individual patients were assessed. ResultsDL models outperformed the conventional NTCP model in both the independent test set (AUC=0.80-0.84 versus 0.76) and external test set (AUC=0.73-0.74 versus 0.63) in AUC and calibration. Attention maps showed a focus on the oral cavity and superior pharyngeal constrictor muscle. ConclusionDL NTCP models performed better than the conventional NTCP model, suggesting the benefit of using 3D-input over the conventional discrete dose parameters. Attention maps highlighted relevant regions linked to dysphagia, supporting the utility of DL for improved predictions.

Neurosurgical evaluation is required in the setting of spinal metastases at high risk for leading to a vertebral body fracture. Both irradiated and nonirradiated vertebrae are affected. Understanding fracture risk is critical in determining management, including follow-up timing and prophylactic interventions. Herein, the authors report the results of a machine learning model that predicts the development or progression of a pathological vertebral compression fracture (VCF) in metastatic tumor-infiltrated thoracolumbar vertebrae in an all-comer population. A multi-institutional all-comer cohort of patients with tumor containing vertebral levels spanning T1 through L5 and at least 1 year of follow-up was included in the study. Clinical features of the patients, diseases, and treatments were collected. CT radiomic features of the vertebral bodies were extracted from tumor-infiltrated vertebrae that did or did not subsequently fracture or progress. Recursive feature elimination (RFE) of both radiomic and clinical features was performed. The resulting features were used to create a purely clinical model, purely radiomic model, and combined clinical-radiomic model. A Spine Instability Neoplastic Score (SINS) model was created for a baseline performance comparison. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity (with 95% confidence intervals) with tenfold cross-validation. Within 1 year from initial CT, 123 of 977 vertebrae developed VCF. Selected clinical features included SINS, SINS component for < 50% vertebral body collapse, SINS component for "none of the prior 3" (i.e., "none of the above" on the SINS component for vertebral body involvement), histology, age, and BMI. Of the 2015 radiomic features, RFE selected 19 to be used in the pure radiomic model and the combined clinical-radiomic model. The best performing model was a random forest classifier using both clinical and radiomic features, demonstrating an AUROC of 0.86 (95% CI 0.82-0.9), sensitivity of 0.78 (95% CI 0.70-0.84), and specificity of 0.80 (95% CI 0.77-0.82). This performance was significantly higher than the best SINS-alone model (AUROC 0.75, 95% CI 0.70-0.80) and outperformed the clinical-only model but not in a statistically significant manner (AUROC 0.82, 95% CI 0.77-0.87). The authors developed a clinically generalizable machine learning model to predict the risk of a new or progressing VCF in an all-comer population. This model addresses limitations from prior work and was trained on the largest cohort of patients and vertebrae published to date. If validated, the model could lead to more consistent and systematic identification of high-risk vertebrae, resulting in faster, more accurate triage of patients for optimal management.

Following successful large-vessel recanalization via endovascular thrombectomy (EVT) for acute ischemic stroke (AIS), some patients experience a complication known as no-reflow, defined by persistent microvascular hypoperfusion that undermines tissue recovery and worsens clinical outcomes. Although prompt identification is crucial, standard clinical practice relies on perfusion magnetic resonance imaging (MRI) within 24 hours post-procedure, delaying intervention. In this work, we introduce the first-ever machine learning (ML) framework to predict no-reflow immediately after EVT by leveraging previously unexplored intra-procedural digital subtraction angiography (DSA) sequences and clinical variables. Our retrospective analysis included AIS patients treated at UCLA Medical Center (2011-2024) who achieved favorable mTICI scores (2b-3) and underwent pre- and post-procedure MRI. No-reflow was defined as persistent hypoperfusion (Tmax > 6 s) on post-procedural imaging. From DSA sequences (AP and lateral views), we extracted statistical and temporal perfusion features from the target downstream territory to train ML classifiers for predicting no-reflow. Our novel method significantly outperformed a clinical-features baseline(AUC: 0.7703 $\pm$ 0.12 vs. 0.5728 $\pm$ 0.12; accuracy: 0.8125 $\pm$ 0.10 vs. 0.6331 $\pm$ 0.09), demonstrating that real-time DSA perfusion dynamics encode critical insights into microvascular integrity. This approach establishes a foundation for immediate, accurate no-reflow prediction, enabling clinicians to proactively manage high-risk patients without reliance on delayed imaging.